Latest research

Overview of some of the research highlights reported at the ECTRIMS 2015 conference in Barcelona.

Study looking at how the menopause affects levels of disability in multiple sclerosis - MS Trust research update

Amy Bowen, our Director of Service Development, reports from ECTRIMS 2015 on what is widely expected to be the most significant MS conference for many years

Investigating the effects of intermittent steroid treatment in people with primary and secondary progressive MS - MS Trust research update

Lifestyle changes and medications to reduce flushing and gastrointestinal (GI) upset when using dimethyl fumarate Tecfidera.

This study looked at people who had taken part in an intense three week rehabilitation programme specifically designed for people with MS.

Study looked at the effect of high blood pressure, high cholesterol, smoking and being overweight on multiple sclerosis.

Working shifts disrupts the body's internal clock and so has an impact on normal body functions. This study looked at the effect of shift work on the risk of developing MS.

A review of studies into swallowing problems in multiple sclerosis finds they are common but estimates vary.

About half of all people with MS have problems at some time with aspects of thinking such as memory, concentration or problem solving.

The human papillomavirus (HPV) vaccine protects against cervical cancer. It was licensed for use in Europe in 2006. This study looked at information to see if developing MS was linked to the HPV vaccination. 

Using yearly tests to see if people with multiple sclerosis can have no evidence of disease activity/NEDA over a long period.